Geode Capital Management, LLC Salarius Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.16 - $0.42 $3,683 - $9,668	23,020 Added 5.9%	413,135 $86,000
Q4 2021 Feb 11, 2022	BUY	$0.49 - $1.01 $16,660 - $34,341	34,001 Added 9.55%	390,115 $193,000
Q3 2021 Nov 12, 2021	BUY	$0.8 - $1.15 $63,263 - $90,940	79,079 Added 28.54%	356,114 $363,000
Q2 2021 Aug 13, 2021	BUY	$1.02 - $1.52 $156,645 - $233,432	153,574 Added 124.39%	277,035 $293,000
Q1 2021 May 12, 2021	BUY	$1.0 - $3.0 $105,131 - $315,393	105,131 Added 573.55%	123,461 $182,000
Q4 2019 Feb 13, 2020	BUY	$3.02 - $5.9 $55,356 - $108,147	18,330 New	18,330 $69,000

Ticker SLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,244,650
Market Cap $3.73M
Description
Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a ...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.